Insights from modeling the 3D structure of New Delhi metallo-β-lactamse and its binding interactions with antibiotic drugs
about
Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping methodTwo birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicineDesign novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approachScaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptorsMolecular Characterization and Computational Modelling of New Delhi Metallo-β-Lactamase-5 from an Escherichia coli Isolate (KOEC3) of Bovine Origin.Insights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1.In vitro transcriptomic prediction of hepatotoxicity for early drug discoveryIdentification of a novel NDM variant, NDM-13, from a multidrug-resistant Escherichia coli clinical isolate in NepaliNR-Drug: predicting the interaction of drugs with nuclear receptors in cellular networking.Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.Small molecular floribundiquinone B derived from medicinal plants inhibits acetylcholinesterase activity.Computational studies on the substrate interactions of influenza A virus PB2 subunit.NDM-4 metallo-β-lactamase with increased carbapenemase activity from Escherichia coli.Molecular dynamics studies on the conformational transitions of adenylate kinase: a computational evidence for the conformational selection mechanism.π-π Stacking mediated drug-drug interactions in human CYP2E1.Computational investigation of theoretical models of cleavable and uncleavable mucin 1 isoforms.Design and synthesis of imidazolidine-2,4-dione derivatives as selective inhibitors by targeting protein tyrosine phosphatase-1B over T-cell protein tyrosine phosphatase.Modelling the molecular mechanism of protein-protein interactions and their inhibition: CypD-p53 case study.
P2860
Q28478196-C9629207-D46A-4432-A4BF-BF7C576884AEQ28478569-4A34D4F8-3E1C-431E-8AD0-C4BB619E6F6DQ28484141-6A8757D2-9FBE-4ADF-A61A-02FD593763E9Q28484657-C4ACE916-0314-4E3A-ABB4-76A586D7CAA1Q30392325-0C09086E-16D1-4A6C-8114-9CF1E258C574Q30412384-E6884781-21CC-44DD-8E88-8A695B64070DQ30423433-59EFC30F-4E61-4867-8A9E-CD8F4C7110B9Q35960769-83135332-F06B-41C2-A1B3-667FDE7B7685Q37684124-984A5A2E-149A-4187-B4C6-DC718321114DQ39771912-BB33038D-B854-4C52-9EA6-31536FD6337AQ41342817-BE4860EA-363E-4A5D-92DE-D7F5CFDD143EQ41811018-70560E80-7236-4254-9E01-0AF9ECCC503AQ42060510-E9705778-57F2-4B20-BD4B-D35688CFF746Q42114141-78817DBA-4C67-40AB-9B12-DE08F484DAA5Q44774734-5DB1BA30-108E-49E8-81F1-0C1F40B0B0A0Q47947458-0EB883CC-F333-46DD-9156-8170D17674EAQ48019500-B6B5B48E-7291-4256-A115-2F3264596AE3Q50955211-C32EC383-DD18-447D-8C43-7CCB8B43F5C3
P2860
Insights from modeling the 3D structure of New Delhi metallo-β-lactamse and its binding interactions with antibiotic drugs
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Insights from modeling the 3D ...... ractions with antibiotic drugs
@ast
Insights from modeling the 3D ...... ractions with antibiotic drugs
@en
Insights from modeling the 3D ...... ractions with antibiotic drugs
@nl
type
label
Insights from modeling the 3D ...... ractions with antibiotic drugs
@ast
Insights from modeling the 3D ...... ractions with antibiotic drugs
@en
Insights from modeling the 3D ...... ractions with antibiotic drugs
@nl
prefLabel
Insights from modeling the 3D ...... ractions with antibiotic drugs
@ast
Insights from modeling the 3D ...... ractions with antibiotic drugs
@en
Insights from modeling the 3D ...... ractions with antibiotic drugs
@nl
P2860
P3181
P1433
P1476
Insights from modeling the 3D ...... ractions with antibiotic drugs
@en
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0018414
P407
P577
2011-04-11T00:00:00Z